Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 28% ± 13% | |
peripheral blood | 13 studies | 25% ± 8% | |
brain | 9 studies | 33% ± 14% | |
eye | 5 studies | 27% ± 7% | |
intestine | 5 studies | 22% ± 10% | |
kidney | 4 studies | 21% ± 2% | |
bone marrow | 4 studies | 18% ± 2% | |
liver | 4 studies | 25% ± 9% | |
pancreas | 3 studies | 45% ± 18% | |
placenta | 3 studies | 21% ± 4% | |
uterus | 3 studies | 31% ± 15% | |
lymph node | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7447.68 | 1445 / 1445 | 100% | 99.16 | 183 / 183 |
prostate | 100% | 6377.64 | 245 / 245 | 100% | 108.24 | 502 / 502 |
stomach | 100% | 4933.26 | 359 / 359 | 100% | 79.90 | 286 / 286 |
brain | 100% | 6378.27 | 2640 / 2642 | 100% | 142.01 | 705 / 705 |
lung | 100% | 7965.27 | 578 / 578 | 100% | 99.32 | 1154 / 1155 |
breast | 100% | 7485.02 | 459 / 459 | 100% | 133.62 | 1117 / 1118 |
thymus | 100% | 7065.80 | 653 / 653 | 100% | 119.39 | 604 / 605 |
intestine | 100% | 6261.86 | 966 / 966 | 100% | 87.50 | 526 / 527 |
uterus | 100% | 6717.01 | 170 / 170 | 100% | 96.13 | 458 / 459 |
ovary | 100% | 5799.17 | 180 / 180 | 100% | 60.27 | 429 / 430 |
bladder | 100% | 6682.81 | 21 / 21 | 100% | 90.74 | 502 / 504 |
liver | 100% | 6755.19 | 226 / 226 | 100% | 63.44 | 404 / 406 |
pancreas | 100% | 3050.23 | 327 / 328 | 99% | 92.27 | 177 / 178 |
kidney | 100% | 5949.07 | 89 / 89 | 99% | 88.45 | 890 / 901 |
skin | 100% | 9769.30 | 1809 / 1809 | 99% | 86.93 | 465 / 472 |
adrenal gland | 100% | 6671.72 | 258 / 258 | 97% | 84.53 | 223 / 230 |
adipose | 100% | 7295.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7122.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 79.93 | 29 / 29 |
muscle | 100% | 4202.33 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6573.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 125.02 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.78 | 1 / 1 |
heart | 99% | 4036.34 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 51.28 | 75 / 80 |
peripheral blood | 87% | 3476.08 | 812 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046907 | Biological process | intracellular transport |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0090382 | Biological process | phagosome maturation |
GO_0034498 | Biological process | early endosome to Golgi transport |
GO_0032880 | Biological process | regulation of protein localization |
GO_0006886 | Biological process | intracellular protein transport |
GO_0032456 | Biological process | endocytic recycling |
GO_0090387 | Biological process | phagolysosome assembly involved in apoptotic cell clearance |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0042742 | Biological process | defense response to bacterium |
GO_0034058 | Biological process | endosomal vesicle fusion |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0006895 | Biological process | Golgi to endosome transport |
GO_0005795 | Cellular component | Golgi stack |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0012505 | Cellular component | endomembrane system |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0042175 | Cellular component | nuclear outer membrane-endoplasmic reticulum membrane network |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005929 | Cellular component | cilium |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0030140 | Cellular component | trans-Golgi network transport vesicle |
GO_0005770 | Cellular component | late endosome |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005791 | Cellular component | rough endoplasmic reticulum |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0019003 | Molecular function | GDP binding |
GO_0031489 | Molecular function | myosin V binding |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB14 |
Protein name | Ras-related protein Rab-14 RAB14, member RAS oncogene family |
Synonyms | |
Description | FUNCTION: Involved in membrane trafficking between the Golgi complex and endosomes during early embryonic development. Regulates the Golgi to endosome transport of FGFR-containing vesicles during early development, a key process for developing basement membrane and epiblast and primitive endoderm lineages during early postimplantation development. May act by modulating the kinesin KIF16B-cargo association to endosomes (By similarity). Regulates, together with its guanine nucleotide exchange factor DENND6A, the specific endocytic transport of ADAM10, N-cadherin/CDH2 shedding and cell-cell adhesion. . |
Accessions | ENST00000451303.1 A0A994J451 ENST00000704000.1 ENST00000703998.1 ENST00000703997.1 X6RFL8 A0A994J4B9 A0A994J774 P61106 ENST00000703996.1 ENST00000373840.9 ENST00000703999.1 |